POM
Showing 1 - 25 of 173
Advanced Solid Tumor Trial in Kansas City (CPX-POM)
Recruiting
- Advanced Solid Tumor
-
Kansas City, KansasUniversity of Kansas Medical Center
Jun 24, 2022
Advanced Solid Tumors Trial in United States (CPX-POM - 30 mg/m^2, CPX-POM - 60 mg/m^2, CPX-POM - 120 mg/m^2)
Completed
- Advanced Solid Tumors
- CPX-POM - 30 mg/m^2
- +7 more
-
Denver, Colorado
- +4 more
Dec 1, 2021
Relapsed Cancer, Refractory Multiple Myeloma, Multiple Myeloma Trial in Boston (Isatuximab, Belantamab mafodotin, Pomalidomide)
Not yet recruiting
- Relapsed Cancer
- +2 more
- Isatuximab
- +3 more
-
Boston, Massachusetts
- +1 more
Jun 19, 2023
Relapsed or Refractory Multiple Myeloma Trial (Daratumumab, Pomalidomide)
Withdrawn
- Relapsed or Refractory Multiple Myeloma
- (no location specified)
Jan 26, 2023
Infectious, Gastro-Intestinal Disorder, Safety Issues Trial in Cleveland (Endoscopic Patient Facemask)
Completed
- Infectious
- +2 more
- Endoscopic Patient Facemask
-
Cleveland, OhioCleveland Clinic Foundation
Aug 16, 2023
Multiple Myeloma, Relapse, Refractory Trial in Chapel Hill, Winston-Salem, Columbus (Isatuximab, Pomalidomide, Dexamethasone)
Not yet recruiting
- Multiple Myeloma
- +4 more
- Isatuximab
- +2 more
-
Chapel Hill, North Carolina
- +2 more
Jun 9, 2023
MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)
Not yet recruiting
- Major Depressive Disorder
- Toludesvenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Sep 7, 2023
MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)
Recruiting
- Major Depressive Disorder
- Toludivenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Jun 14, 2023
Preterm Birth Complication Trial in Boston (SENSE-plus: The Supporting and Enhancing NICU Sensory Experiences 2nd Edition (SENSE
Recruiting
- Preterm Birth Complication
- SENSE-plus: The Supporting and Enhancing NICU Sensory Experiences 2nd Edition (SENSE II) program
- +2 more
-
Boston, MassachusettsBrigham and Women's Hospital
Sep 19, 2023
PROM Trial in Philadelphia (Misoprostol, Oxytocin)
Recruiting
- PROM
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Jul 18, 2022
Socket Sealing, Free Gingival Graft, Collagen Membrane Trial in Ann Arbor (Socket preservation)
Completed
- Socket Sealing
- +2 more
- Socket preservation
-
Ann Arbor, MichiganUM - POM Dpt
Jul 1, 2022
Multiple Myeloma in Relapse Trial in Denver, Saint Louis, Toronto (Elotuzumab, Pomalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma in Relapse
- Elotuzumab
- +2 more
-
Denver, Colorado
- +2 more
Oct 14, 2021
Type 2 Diabetes, Multidisciplinary Communication, Empowerment Trial in Hasselt (visualisation of a digital care path)
Recruiting
- Type 2 Diabetes
- +4 more
- visualisation of a digital care path
-
Hasselt, Limburg, BelgiumJessa Hospital
Feb 7, 2022
Multiple Myeloma Trial in Torino (Pomalidomide, Cyclophosphamide, Dexamethasone)
Terminated
- Multiple Myeloma
- Pomalidomide
- +2 more
-
Torino, ItalyFondazione EMN Italy Onlus
Feb 16, 2021
Prostate Cancer Trial in Los Angeles (pomegranate juice)
Completed
- Prostate Cancer
- pomegranate juice
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Jun 1, 2021
Disorder of Oral Mucous Membrane Trial in Ann Arbor (EVPOME (autogenous ex vivo produced oral mucosa equivalent), POM (Palatal
Terminated
- Disorder of Oral Mucous Membrane
- EVPOME (autogenous ex vivo produced oral mucosa equivalent)
- POM (Palatal oral mucosa)
-
Ann Arbor, MichiganUniversity of Michigan, Department of Oral & Maxxillofacial Surg
Aug 9, 2021
Postoperative Myalgia Trial in Assiut (Placebo, Selenium)
Completed
- Postoperative Myalgia
- Placebo
- Selenium
-
Assiut, EgyptAssiut university hospital
Oct 15, 2020
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pom/dex (Pomalidomide plus low dose Dexamethasone))
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
- Pom/dex (Pomalidomide plus low dose Dexamethasone)
-
Tucson, Arizona
- +163 more
Feb 25, 2022
Intrauterine Growth Restriction Trial in Boston (Pomegranate Juice, Placebo Juice)
Active, not recruiting
- Intrauterine Growth Restriction
- Pomegranate Juice
- Placebo Juice
-
Boston, MassachusettsBrigham and Women's Hospital
Sep 14, 2020
Healthy Volunteers Trial in Los Angeles (POMx, Placebo)
Completed
- Healthy Volunteers
- POMx
- Placebo
-
Los Angeles, CaliforniaUCLA Longevity Center
Feb 28, 2020
Impact of Pomegranate Juice on Memory in Older Adults Trial in Los Angeles (Pomegranate Juice, Placebo)
Completed
- Impact of Pomegranate Juice on Memory in Older Adults
- Pomegranate Juice
- Placebo
-
Los Angeles, CaliforniaUCLA Longevity Center
Feb 28, 2020
Multiple Myeloma Trial in Worldwide (Durvalumab, Pomalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Durvalumab
- +2 more
-
Little Rock, Arkansas
- +34 more
Aug 4, 2021
Multiple Myeloma Trial in France, Spain, United States (Daratumumab, Velcade, Pomalidomide)
Active, not recruiting
- Multiple Myeloma
- Daratumumab
- +11 more
-
Duarte, California
- +21 more
Jan 17, 2023